Lewis C Perrin
Overview
Explore the profile of Lewis C Perrin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
239
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Faber-Swensson A, Perrin L, Nicklin J
Aust N Z J Obstet Gynaecol
. 2015 Jun;
55(3):298-9.
PMID: 26084196
No abstract available.
12.
Webb P, Fazio A, Protani M, Ibiebele T, Nagle C, Brand A, et al.
Am J Clin Nutr
. 2015 May;
102(1):109-14.
PMID: 25971716
Background: Vitamin D status might be associated with cancer survival. Survival after ovarian cancer is poor, but the association with vitamin D has rarely been examined. Objective: We evaluated the...
13.
Baker J, Janda M, Graves N, Bauer J, Banks M, Garrett A, et al.
Gynecol Oncol
. 2015 Apr;
137(3):516-22.
PMID: 25827292
Background: Malnutrition is common in patients with advanced epithelial ovarian cancer (EOC), and is associated with impaired quality of life (QoL), longer hospital stay and higher risk of treatment-related adverse...
14.
Faber-Swensson A, Perrin L, Nicklin J
Aust N Z J Obstet Gynaecol
. 2014 Oct;
54(5):450-2.
PMID: 25287560
Background: Radical trachelectomy and pelvic lymph node dissection are an increasingly recognised treatment for early cervical cancer in women wishing to retain their fertility. Aims: To analyse and summarise the...
15.
Armes J, Davies C, Wallace S, Taheri T, Perrin L, Autelitano D
Pathology
. 2012 Dec;
45(1):49-54.
PMID: 23222243
Aims: To examine AGR2 expression in ovarian epithelial tumours and its potential role as a prognostic biomarker. Methods: Tissue microarray technology and immunohistochemistry were used to investigate AGR2 expression in...
16.
Obermair A, Mileshkin L, Bolz K, Kondalsamy-Chennakesavan S, Cheuk R, Vasey P, et al.
Gynecol Oncol
. 2010 Dec;
120(2):179-84.
PMID: 21126755
Objective: Uterine Papillary Serous Carcinoma (UPSC) is uncommon and accounts for less than 5% of all uterine cancers. Therefore the majority of evidence about the benefits of adjuvant treatment comes...
17.
Pak S, Martens M, Bekkers R, Crandon A, Land R, Nicklin J, et al.
Aust N Z J Obstet Gynaecol
. 2007 Nov;
47(6):504-7.
PMID: 17991118
Background: Since the introduction of the Pap smear screening, the incidence of squamous cell carcinoma (SCC) has decreased significantly, but the incidence of adenocarcinoma (AC) relative to SCC has increased....
18.
Smith C, Heeren M, Nicklin J, Perrin L, Land R, Crandon A, et al.
Gynecol Oncol
. 2007 Jul;
107(1):124-9.
PMID: 17655917
Objective: To evaluate the efficacy of routine follow-up in patients with recurrent uterine cancer. Methods: In a single institution study, a total of 2637 patients were treated curatively for uterine...
19.
Garrett A, Nascimento M, Nicklin J, Perrin L, Obermair A
Aust N Z J Obstet Gynaecol
. 2007 Jan;
47(1):65-9.
PMID: 17261104
Background: Total laparoscopic hysterectomy (TLH) is becoming more commonly used for gynaecological malignancies. Aims: To describe our experience with TLH since its introduction to our tertiary referral centre for gynaecological...
20.
Janda M, Obermair A, Cella D, Perrin L, Nicklin J, Ward B, et al.
Gynecol Oncol
. 2005 May;
97(2):568-75.
PMID: 15863161
Objectives: To assess the reliability and validity of the Functional Assessment of Cancer Therapy-Vulvar (FACT-V). Methods: Seventy-seven patients treated between January 1996 and January 2001 for cancer of the vulva...